First hybrid gene therapy shows early promise in treating long QT syndrome
Drug prices in the US are 2.56 times those in other nations
28 January 2021Sleep, heart health, . . . and other stories
28 January 2021First hybrid gene therapy shows early promise in treating long QT syndrome
In a new study published in Circulation, Mayo Clinic researchers provide the first preclinical, proof-of-concept study for hybrid gene therapy in long QT syndrome, a potentially lethal heart rhythm condition.
